Nutra Pharma announces the publication of their study outlining the mechanism of action of their pain drugs to be published in the journal Neuropharmacology. November 30, 2011 — Coral Springs, Florida — Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and [...]



